Vanda Pharmaceuticals, Inc. (VNDA)
3.755
-0.06
(-1.44%)
USD |
NASDAQ |
Nov 18, 16:00
3.755
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Price : 3.755 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 3.81 | 3.90 | 3.78 | 3.81 | 830315.0 |
| Nov 16, 2026 | 3.95 | 3.97 | 3.735 | 3.81 | 839296.0 |
| Nov 13, 2026 | 3.93 | 4.01 | 3.805 | 3.99 | 824785.0 |
| Nov 12, 2026 | 4.13 | 4.175 | 3.94 | 3.95 | 1.247M |
| Nov 11, 2026 | 4.155 | 4.195 | 4.06 | 4.15 | 688432.0 |
| Nov 10, 2026 | 4.00 | 4.18 | 4.00 | 4.08 | 1.381M |
| Nov 09, 2026 | 3.83 | 4.11 | 3.724 | 4.09 | 1.673M |
| Nov 06, 2026 | 3.63 | 3.85 | 3.61 | 3.82 | 896877.0 |
| Nov 05, 2026 | 3.88 | 3.88 | 3.565 | 3.59 | 1.249M |
| Nov 04, 2026 | 3.79 | 3.91 | 3.725 | 3.88 | 1.189M |
| Nov 03, 2026 | 3.88 | 3.949 | 3.64 | 3.75 | 1.804M |
| Nov 02, 2026 | 3.80 | 3.95 | 3.70 | 3.88 | 1.918M |
| Oct 30, 2026 | 4.03 | 4.11 | 3.74 | 3.79 | 1.793M |
| Oct 29, 2026 | 4.455 | 4.640 | 3.955 | 4.05 | 2.704M |
| Oct 28, 2026 | 3.96 | 4.08 | 3.79 | 4.00 | 2.035M |
| Oct 27, 2026 | 4.04 | 4.11 | 3.88 | 3.99 | 1.857M |
| Oct 26, 2026 | 4.00 | 4.105 | 3.915 | 3.94 | 810903.0 |
| Oct 23, 2026 | 4.04 | 4.07 | 3.875 | 4.01 | 830813.0 |
| Oct 22, 2026 | 4.01 | 4.125 | 3.96 | 4.05 | 604826.0 |
| Oct 21, 2026 | 4.18 | 4.18 | 3.965 | 4.01 | 1.088M |
| Oct 20, 2026 | 4.11 | 4.315 | 4.10 | 4.17 | 857181.0 |
| Oct 19, 2026 | 4.06 | 4.12 | 4.035 | 4.09 | 671316.0 |
| Oct 16, 2026 | 4.25 | 4.27 | 3.995 | 4.03 | 1.050M |
| Oct 15, 2026 | 4.04 | 4.305 | 4.01 | 4.24 | 1.047M |
| Oct 14, 2026 | 4.29 | 4.39 | 4.20 | 4.22 | 1.063M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| SELLAS Life Sciences Group, Inc. | 17.94 |
| Sagimet Biosciences, Inc. | 10.10 |
| ACADIA Pharmaceuticals, Inc. | 17.84 |
| Alnylam Pharmaceuticals, Inc. | 149.48 |
| Anika Therapeutics, Inc. | 13.62 |
Price Related Metrics
| PS Ratio | 0.9796 |
| PEG Ratio | -0.0036 |
| Price to Book Value | 1.136 |
| Earnings Yield | -123.0% |
| Market Cap | 227.06M |
| PEGY Ratio | -0.0036 |